BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 28418607)

  • 1. Current trends in quantitative proteomics - an update.
    Li H; Han J; Pan J; Liu T; Parker CE; Borchers CH
    J Mass Spectrom; 2017 May; 52(5):319-341. PubMed ID: 28418607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization approaches in absolute quantitative proteomics with mass spectrometry.
    Calderón-Celis F; Encinar JR; Sanz-Medel A
    Mass Spectrom Rev; 2018 Nov; 37(6):715-737. PubMed ID: 28758227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol for Standardizing High-to-Moderate Abundance Protein Biomarker Assessments Through an MRM-with-Standard-Peptides Quantitative Approach.
    Percy AJ; Yang J; Chambers AG; Mohammed Y; Miliotis T; Borchers CH
    Adv Exp Med Biol; 2016; 919():515-530. PubMed ID: 27975233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four areas of engagement requiring strengthening in modern proteomics today.
    Fehniger TE; Boja ES; Rodriguez H; Baker MS; Marko-Varga G
    J Proteome Res; 2014 Dec; 13(12):5310-8. PubMed ID: 25405748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaching clinical proteomics: current state and future fields of application in fluid proteomics.
    Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tarnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Verhuven W; Wagener C; Wagner O; Schmitz G
    Clin Chem Lab Med; 2009; 47(6):724-44. PubMed ID: 19527139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review on recent developments in mass spectrometry instrumentation and quantitative tools advancing bacterial proteomics.
    Van Oudenhove L; Devreese B
    Appl Microbiol Biotechnol; 2013 Jun; 97(11):4749-62. PubMed ID: 23624659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical biomarker discovery by SWATH-MS based label-free quantitative proteomics: impact of criteria for identification of differentiators and data normalization method.
    Narasimhan M; Kannan S; Chawade A; Bhattacharjee A; Govekar R
    J Transl Med; 2019 May; 17(1):184. PubMed ID: 31151397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometry-based targeted quantitative proteomics: achieving sensitive and reproducible detection of proteins.
    Boja ES; Rodriguez H
    Proteomics; 2012 Apr; 12(8):1093-110. PubMed ID: 22577011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SRM/MRM targeted proteomics as a tool for biomarker validation and absolute quantification in human urine.
    Mermelekas G; Vlahou A; Zoidakis J
    Expert Rev Mol Diagn; 2015; 15(11):1441-54. PubMed ID: 26472065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orbitrap mass spectrometry.
    Zubarev RA; Makarov A
    Anal Chem; 2013 Jun; 85(11):5288-96. PubMed ID: 23590404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted mass spectrometry approaches for protein biomarker verification.
    Meng Z; Veenstra TD
    J Proteomics; 2011 Nov; 74(12):2650-9. PubMed ID: 21540133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
    Findeisen P; Neumaier M
    Clin Chem Lab Med; 2009; 47(6):666-84. PubMed ID: 19445650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current trends in quantitative proteomics.
    Elliott MH; Smith DS; Parker CE; Borchers C
    J Mass Spectrom; 2009 Dec; 44(12):1637-60. PubMed ID: 19957301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SWATH-MS as a tool for biomarker discovery: From basic research to clinical applications.
    Anjo SI; Santa C; Manadas B
    Proteomics; 2017 Feb; 17(3-4):. PubMed ID: 28127880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometry-based biomarker discovery: toward a global proteome index of individuality.
    Hawkridge AM; Muddiman DC
    Annu Rev Anal Chem (Palo Alto Calif); 2009; 2():265-77. PubMed ID: 20636062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative mass spectrometry in proteomics: a critical review.
    Bantscheff M; Schirle M; Sweetman G; Rick J; Kuster B
    Anal Bioanal Chem; 2007 Oct; 389(4):1017-31. PubMed ID: 17668192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker discovery in mass spectrometry-based urinary proteomics.
    Thomas S; Hao L; Ricke WA; Li L
    Proteomics Clin Appl; 2016 Apr; 10(4):358-70. PubMed ID: 26703953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress in mass spectrometry proteomics for biomedical research.
    Li X; Wang W; Chen J
    Sci China Life Sci; 2017 Oct; 60(10):1093-1113. PubMed ID: 29039124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical validation considerations of multiplex mass-spectrometry-based proteomic platforms for measuring protein biomarkers.
    Boja ES; Fehniger TE; Baker MS; Marko-Varga G; Rodriguez H
    J Proteome Res; 2014 Dec; 13(12):5325-32. PubMed ID: 25171765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isotope dilution strategies for absolute quantitative proteomics.
    Brun V; Masselon C; Garin J; Dupuis A
    J Proteomics; 2009 Jul; 72(5):740-9. PubMed ID: 19341828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.